Henry Schein (HSIC) shares jumped 5.18% in intraday trading after the company reported stronger-than-expected second-quarter results and lifted its fiscal 2026 outlook, driven by robust demand for dental supplies.

For the quarter ended June 27, adjusted earnings came in at $1.27 per share, surpassing the $1.24 consensus estimate. Net sales rose 6.7% to $3.46 billion, also beating the $3.38 billion analysts expected. The Global Distribution and Value-Added Services segment grew 6.6%, while the Global Specialty Products segment, which includes dental implants and biomaterials, jumped 8.7%.

The company raised its full-year 2026 guidance, now forecasting adjusted EPS of $5.29 to $5.39, up from the prior $5.23 to $5.37 range, and revenue growth of 4.5% to 5.5%, up from 3% to 5%. Management noted the guidance does not include any remeasurement gains or potential tariff refund benefits, signaling confidence in underlying business momentum.